Health policy

Evidence gaps and challenges in maintaining and increasing vaccine uptake: A Delphi survey with Australian stakeholders – Penelope Robinson et al.

2024-08-02T11:54:59+10:00COVID-19, Health policy, Public comprehension, Publications|

Increasing and maintaining vaccination uptake is crucial for preventing and managing infectious diseases. In the context of the post-coronavirus disease 2019 (COVID-19) pandemic landscape, this paper examines the perceptions of immunisation implementers and policymakers to uncover the challenges and evidence gaps in routine immunisation efforts.

Development and validation of the Vaccine Barriers Assessment Tool for identifying drivers of under-vaccination in children under five years in Australia – Jessica Kaufman et al.

2024-08-02T11:45:52+10:00COVID-19, Health literacy, Health policy, Publications, Risk|

Data on routine childhood vaccination coverage can only tell us who is under-vaccinated; it cannot explain why vaccine coverage is low. Collecting data on the reasons behind under-vaccination is necessary to implement cost-effective strategies that address key barriers and target interventions appropriately. However, no instruments [...]

Breast cancer screening from age 40 in the US – Katy JL Bell et al.

2024-07-30T11:45:58+10:00Breast cancer, Cancer, Health policy, Overdiagnosis, Publications, Risk, Screening, Women's health|

The US Preventive Services Task Force has updated its recommendation for the age when all women should start mammography screening, lowering it from 50 to 40. This change immediately affects more than 20 million American women and other people assigned female at birth who are [...]

Children’s voices must be included in policy development to mitigate society’s betrayal of children – Susan dosReis et al.

2024-04-12T12:00:43+10:00Climate change, Health policy, Mental Health, Publications|

Abbasi’s assertion of “society’s betrayal of children, their health, and our future” and the appalling decline in child health is sobering. The International Network for Epidemiology in Policy (INEP) represents 24 epidemiology societies across the globe and works to tackle policies that have global public [...]

‘Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives – Didu S. Kariyawasam et al.

2024-04-05T14:50:00+11:00Ethical considerations, Genetic testing, Genomics, Health policy, Publications, Risk, Screening|

Newborn bloodspot screening is a well-established population health initiative that detects serious, childhood-onset, treatable conditions to improve health outcomes. With genomic technologies advancing rapidly, many countries are actively discussing the introduction of genomic assays into newborn screening programs. While adding genomic testing to Australia’s newborn [...]

Can evidence drive health equity in the COVID-19 pandemic and beyond? – Katy Bell et al.

2024-02-11T15:23:27+11:00COVID-19, Health policy, Health system, Patient-led surveillance, Policy, Publications, Risk|

Using scoping review methods, we systematically searched multiple online databases for publications in the first year of the pandemic that proposed pragmatic population or health system-level solutions to health inequities. We found 77 publications with proposed solutions to pandemic-related health inequities. Most were commentaries, letters, [...]

Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis – Louisa Picco et al.

2023-12-04T14:13:26+11:00Health policy, Mental Health, Opioids, Pain, Prescribing, Publications, Risk|

Prescription drug monitoring programs (PDMP) are increasingly used to identify people prescribed high-dose opioids. However, little is known about whether PDMPs impact opioid agonist treatment (OAT) uptake, the gold standard for opioid use disorder. This study examined the impact of PDMP implementation on OAT initiation [...]

“It’s not a one operation fits all”: A qualitative study exploring fee setting and participation in price transparency initiatives amongst medical specialists in the Australian private healthcare sector – Hana Sabanovic et al.

2023-12-04T12:53:51+11:00Ethical considerations, Health policy, Health professionals, Health system, Insurance, Low-value care, Publications|

The Australian government, through Medicare, defines the type of medical specialist services it covers and subsidizes, but it does not regulate prices. Specialists in private practice can charge more than the fee listed by Medicare depending on what they feel ‘the market will bear’. This [...]

Determining the Impact of Opioid Policy on Substance Use and Mental Health–Related Harms: Protocol for a Data Linkage Study Determining the Impact of Opioid Policy on Substance Use and Mental Health–Related Harms: Protocol for a Data Linkage Study – Ting Xia et al.

2023-12-04T12:35:25+11:00Health policy, Mental Health, Opioids, Prescribing, Primary Care, Publications|

Increasing harms related to prescription opioids over the past decade have led to the introduction of a range of key national and state policy initiatives across Australia. These include introducing a mandatory real-time prescription drug–monitoring program in the state of Victoria from April 2020 and [...]

Go to Top